![Christopher Mason](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Christopher Mason
Direttore/Membro del Consiglio presso KRYSTAL BIOTECH, INC.
Patrimonio netto: - $ in data 30/06/2024
Posizioni attive di Christopher Mason
Società | Posizione | Inizio | Fine |
---|---|---|---|
KRYSTAL BIOTECH, INC. | Direttore/Membro del Consiglio | 04/01/2021 | - |
Independent Dir/Board Member | 04/01/2021 | - | |
Oribiotech Ltd.
![]() Oribiotech Ltd. BiotechnologyHealth Technology Oribiotech Ltd. Engages in Cell and Gene Therapy (CGT) manufacturing. The company was founded by Farlan Veraitch and Chris Mason on September 2, 2015 and is headquartered in London, the United Kingdom. | Direttore/Membro del Consiglio | 01/09/2015 | - |
Fondatore | 01/09/2015 | - | |
London Regenerative Medicine Network Ltd. | Direttore/Membro del Consiglio | 01/02/2008 | - |
Fondatore | 01/02/2008 | - | |
University College London | Corporate Officer/Principal | - | - |
Alliance for Regenerative Medicine
![]() Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Direttore/Membro del Consiglio | 01/10/2021 | - |
Storia della carriera di Christopher Mason
Precedenti posizioni note di Christopher Mason
Società | Posizione | Inizio | Fine |
---|---|---|---|
TECTONIC THERAPEUTIC, INC. | Direttore Tecnico/Scientifico/R&S | 01/07/2015 | 30/06/2022 |
Fondatore | 01/07/2015 | 30/06/2022 | |
Stem Cell Translation Ltd. | Direttore/Membro del Consiglio | 01/10/2006 | 01/03/2018 |
Fondatore | 01/10/2006 | 01/03/2018 | |
The British Neurological Research Trust | Direttore/Membro del Consiglio | 01/05/2012 | 01/05/2016 |
UK Stem Cell Foundation | Direttore/Membro del Consiglio | 01/09/2010 | 01/05/2016 |
Formazione di Christopher Mason
Imperial College London | Undergraduate Degree |
University College London | Doctorate Degree |
King's College London | Doctorate Degree |
Statistiche
Distribuzione geografica
Regno Unito | 9 |
Stati Uniti | 4 |
Posizioni
Director/Board Member | 8 |
Founder | 5 |
Doctorate Degree | 2 |
Settori
Consumer Services | 4 |
Health Technology | 4 |
Miscellaneous | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
KRYSTAL BIOTECH, INC. | Health Technology |
Aziende private | 7 |
---|---|
UK Stem Cell Foundation | Miscellaneous |
Alliance for Regenerative Medicine
![]() Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Health Services |
The British Neurological Research Trust | |
Avrobio, Inc.
![]() Avrobio, Inc. BiotechnologyHealth Technology AVROBIO, Inc. engages in the development of lentiviral-based gene therapies. It focuses on developing potentially curative ex vivo lentiviral-based gene therapies to treat patients with rare diseases following a single dose treatment regimen. The firm's clinical-stage programs include Fabry, Gaucher Type 1, Hunter syndrome Gaucher Type 3, Pompe, and Cystinosis. The company was founded by Geoff Mackay, Kim Warren, Christopher Mason, and Jeffrey Medin in 2015 and is headquartered in Watertown, MA. | Health Technology |
Oribiotech Ltd.
![]() Oribiotech Ltd. BiotechnologyHealth Technology Oribiotech Ltd. Engages in Cell and Gene Therapy (CGT) manufacturing. The company was founded by Farlan Veraitch and Chris Mason on September 2, 2015 and is headquartered in London, the United Kingdom. | Health Technology |
London Regenerative Medicine Network Ltd. | |
Stem Cell Translation Ltd. |
- Borsa valori
- Insiders
- Christopher Mason
- Esperienza